VPHM – Cinryze sBLA for acute HAE gets FDA priority review: <a href="http://finance.yahoo.com/news/FDA-Grants-Priority-Review-of-prnews-14237399.html" target="_blank">http://finance.yahoo.com/news/FDA-Grants-Priority-Review-of-prnews-14237399.html</a> Interesting timing vis-à-vis the DYAX advisory panel tomorrow in the same indication.